Orchard Therapeutics plc is a biotechnology company dedicated to developing gene therapies for rare diseases. With a focus on ex vivo gene therapy, Orchard aims to transform the lives of patients by providing long-term solutions to their conditions. Through strategic partnerships and innovative research, the company is paving the way for groundbreaking treatments and advancements in the field.
